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Background: Young people with 22q11.2 deletion syndrome (22q11.2DS) are at high risk for 
neurodevelopmental disorders. Sleep problems may play a role in this risk but their 
prevalence, nature and links to psychopathology and cognitive function remain undescribed 
in this population. 
Method: Sleep problems, psychopathology, developmental coordination and cognitive 
function were assessed in 140 young people with 22q11.2DS (mean age=10.1, SD=2.46) and 
65 unaffected sibling controls (mean age=10.8, SD=2.26). Primary carers completed 
questionnaires screening for the children’s developmental coordination and autism spectrum 
disorder.   
Results: Sleep problems were identified in 60% of young people with 22q11.2DS compared 
to 23% of sibling controls (OR=5.00, p<0.001). Two patterns best described sleep problems 
in 22q11.2DS: restless sleep and insomnia. Restless sleep was linked to increased ADHD 
symptoms (OR=1.16, p<0.001) and impaired executive function (OR=0.975, p=0.013). Both 
patterns were associated with elevated symptoms of anxiety disorder (restless sleep: 
OR=1.10, p=0.006 and insomnia: OR=1.07, p=0.045) and developmental coordination 
disorder (OR=0.968, p=0.0023, and OR=0.955, p=0.009). The insomnia pattern was also 
linked to elevated conduct disorder symptoms (OR=1.53, p=0.020). 
Conclusions:  Clinicians and carers should be aware that sleep problems are common in 
22q11.2DS and index psychiatric risk, cognitive deficits and motor coordination problems. 
Future studies should explore the physiology of sleep and the links with the neurodevelopment 
in these young people.  
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Introduction 
22q11.2 Deletion Syndrome (22q11.2DS) is a genetic disorder characterised by a hemizygous 
deletion of ~50 genes on the long arm of chromosome 22 (Swillen et al. 2015) and is one of 
the strongest known biological risk factors for development of schizophrenia (Monks et al., 
2014; Schneider et al., 2014). It is associated with congenital physical abnormalities (e.g., 
heart defect, cleft palate) (McDonald-McGinn et al., 2001) and a range of neurodevelopmental 
problems (Schneider et al., 2014; Niarchou et al., 2015; Chawner et al., 2017; Cunningham et 
al., 2017) including an increased risk of ADHD (12-68%), anxiety disorders (in 40-76%), 
oppositional defiant disorder (ODD) (in 9-43%), autism spectrum disorder (ASD) (in 14-50%) 
(Schneider et al., 2014) and motor coordination problems (> 80%) (Cunningham et al., 2017) 
of young people with 22q11.2DS. Comorbid psychiatric presentation is common in individuals 
with 22q11.2DS, with 54% of children with 22q11.2DS reported to meet diagnostic criteria for 
one or more DSM-IV-TR psychiatric disorders (Niarchou et al., 2014) and a recent large-scale 
study has documented evidence of widespread structural brain abnormalities (Sun et al., 
2018). In addition, the average IQ is ~30 IQ points lower than in typically developing children 
(Niarchou et al., 2014) and a range of deficits in specific cognitive functions have also been 
reported, including reaction time, sustained attention, processing speed, spatial working 
memory and executive function (Hooper et al., 2013; Niarchou et al., 2014).  
Sleep problems have yet to be formally acknowledged as part of the 22q11.2DS phenotype 
despite anecdotal reports of their presence. The limited evidence of sleep problems that is 
available in 22q11.2DS has focused on sleep-related breathing disorders that arise from 
airway obstruction caused by craniofacial dysmorphia of the syndrome (Heike et al., 2007; 
Crockett et al., 2014; Kennedy et al., 2014). These small-scale studies and case reports have 
shown evidence for obstructive sleep apnoea in an estimated 10% of young people with 
22q11.2DS, compared to only 2-4% in typically developing children (Chang et al., 2010; 
Kennedy et al., 2014). Furthermore, neurodevelopmental disorders (NDD) such as ADHD and 
Studies not specifically focussing on 22q11.2DS have provided evidence of elevated rates of 
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sleep problems in individuals with neurodevelopmental disorders (NDD) such as ADHD and 
ASD, with reported rates  as high as 86% (Wiggs 2001; Robinson-Shelton and Malow. 2016). 
Rates of sleep problems between 40-80% have been reported in individuals with ASD 
(Souders et al., 2009), 25-50% in individuals with ADHD (Corkum et al. 1998; Spruyt et al. 
2011) and 88% of those with anxiety disorders (88%) (Staner, 2003). These findings suggest 
that sleep problems could be prominent in individuals with 22q11.2DS.  
To our knowledge this is the first study to address the prevalence and nature of sleep problems 
and their links with psychopathology and cognitive function in 22q11.2DS.  
Specifically, we aimed to address the gap in the literature by: 1) quantifying the prevalence of 
sleep problems in a cohort of young people with 22q11.2DS compared to sibling controls; 2) 
describing the patterns of sleep problems in young people with 22q11.2DS and; 3) 
investigating the links between sleep problems and neurodevelopmental and cognitive 
outcomes in young people with 22q11.2DS.  
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Methodology 
Participants 
Participants were part of the ongoing Experiences of Children with cOpy number variants 
(ECHO) study (https://www.cardiff.ac.uk/mrc-centre-neuropsychiatric-genetics-genomics 
/research/themes/developmental-disorders/echo-study-cnv-research). Young people with 
22q11.2DS were recruited through NHS Medical Genetics clinics in the UK, British 22q11.2DS 
charities (Max Appeal! 22qCrew and Unique), social media and family networks. Where 
available, a sibling without the deletion (sibling control) closest in age to the child with 
22q11.2DS was also invited to take part in the ECHO study. The availability of this sibling 
control sample enabled us to conduct comparisons with a typically developing sample to 
quantify the extent of sleep problems in 22q11.2DS as well as conduct pairwise comparisons 
between case-control sibling pairs, therefore considering shared genetic background and 
family environmental factors.  Carriers of the deletion and sibling controls were aged 6 or older 
and the presence (in carriers) or absence (in sibling controls) of the deletion was confirmed 
by a Medical Genetics laboratory and/or microarray analysis in the MRC Centre for 
Neuropsychiatric Genetics and Genomics laboratory at Cardiff University. The current study 
focussed on 140 young people with 22q11.2DS (x̅ age =10.1, range = 6 years 3 month–17 
years 1 month, SD= 2.45, 45.0% females) and 65 age-matched sibling controls (x̅ age = 10.8, 
range = 6 years 1 month –16 years 7 months, SD= 2.26, 43.1% females). Family income 
information was obtained from questionnaires completed by the primary carer and can be 
found together with information of the age and gender of the participants in Table 1.  
Of the participants with 22q11.2DS 17 were taking melatonin for sleep problems; one used 
antipsychotic medication aripiprazole for psychotic experiences; one risperidone for mood 
disorder and none were using ADHD medication. Parents reported a diagnosis of epilepsy in 
10.7% (15/140) of participants with 22q11.2DS. Two children with 22q11.2DS were using 
sodium valproate for epilepsy. Prior to recruitment, primary carers consented for all 
participants and additional consent was obtained from participants aged ≥16 years with 
   
 
7 
 
capacity. The protocols used in this study were approved by NHS South East Wales Research 
Ethics Committee.  
Assessments  
Psychopathology and neurodevelopmental assessment 
The semi-structured Child and Adolescent Psychiatric Assessment (CAPA) (Angold et al., 
1995) was conducted with the primary carer, and young people with capacity were themselves 
interviewed about their mood, anxiety and psychotic experiences with the child CAPA. All 
interviews were conducted by trained psychologists, and taped for monitoring and the scoring 
of symptoms. Attribution of diagnoses according to the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV TR) was discussed in consensus meetings led by child and 
adolescent psychiatrists.   
The anxiety disorder symptom score included symptoms of generalised anxiety disorder, 
social phobia, specific phobia, separation anxiety, and panic disorder with and without 
agoraphobia, agoraphobia and obsessive-compulsive disorder. ADHD symptoms included the 
subscales of hyperactivity and impulsivity and inattention, ODD symptoms the subscales 
oppositional behaviour and deception, and conduct disorder (CD) symptoms the subscales of 
acts involving violence and violence against persons.  
ASD symptoms were screened for with the Social Communication Questionnaire (SCQ) 
(Rutter et al. 2003) completed by the primary carer (referred to as indicative ASD from here 
onwards). The total indicative ASD score comprised three subscales: social interaction, 
communication, and restrictive and repetitive traits. SCQ total scores were available for a 
subsample of 128 young people with 22q11.2DS.  
Symptom scores of psychopathologies were calculated by summing individual scores ranging 
from 0 to 26 for anxiety disorder, 0 to 16 for ADHD,  0 to 6 for ODD, 0 to 4 for CD and 0 to 34 
for indicative ASD as in previous studies (Niarchou et al., 2014; Chawner et al., 2017; 
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Cunningham et al., 2017). A symptom score of ≥15 on the SCQ is considered to be indicative 
of ASD (Berument et al., 1999).  
Sleep problems 
Sleep problems over the preceding three months were established by interview with the 
primary carer using the sleep section of the CAPA. This section includes 11 questions (see 
Table 2): insomnias (trouble initiating sleep, trouble maintaining sleep and early morning 
awakening without being able to return to sleep); hypersomnia (excessive daytime sleepiness, 
extended sleep duration); restless sleep (inability to get comfortable and feel rested for the 
night); inadequately rested sleep (lack of restorative and maintained sleep); fatigue and 
tiredness (feelings of being tired at least half the time), and becoming tired or ‘worn out’ more 
easily than usual) and parasomnias (nightmares, night terrors and sleepwalking). This CAPA 
section screens for the presence of sleep problems but does not provide a sleep disorder 
diagnosis, which would require additional assessments including polysomnography conducted 
by clinicians. Items were coded “0 = absent” or “1 = present” and positive scores of the 11 
items were summed to obtain an overall sleep problem score (Table 2) ranging from 0-7.  
Developmental coordination problems 
Indicative Developmental Coordination Disorder (DCD) was established using the DCD 
Questionnaire (DCDQ) (Wilson et al., 2009) completed by the primary carer. The DCDQ 
screens for motor coordination impairments with scores ranging from 15 to 75. Lower scores 
indicate greater coordination problems with discrimination thresholds based on age 
(Cunningham et al., 2017). We introduced this measure later in our study and therefore have 
available information from 97 young people with 22q11.2DS. 
IQ  
The Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler, 1999) was used to assess 
full-scale IQ (FSIQ), performance IQ (PIQ) and verbal IQ (VIQ). 
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Cognitive performance  
The Cambridge Neuropsychological Test Automated Battery (CANTAB) (Cambridge 
Cognition Ltd, 2006) was used to assess of the following cognitive performances: spatial 
working memory (number of errors on the spatial working memory (SWM) task); spatial 
planning (number of problems solved on the Stockings of Cambridge (SOC) task); processing 
speed (reaction time in milliseconds on the Five-choice reaction time (RTI) task); visual 
attention (number of correct items on the Match-to-Sample Visual Search (MTS) task) and 
sustained attention (ability to distinguish the target stimuli from the distractor stimuli during the 
Rapid Visual Processing (RVP) task. All CANTAB scores were age- except for MTS where no 
CANTAB norms are available and raw scores were used. The Wisconsin Card Sorting Test 
(WCST) (Heaton et al., 1993) was used to measure outcomes of perseverative (set-shifting) 
and non-perseverative (random) errors. 
All measures in this study were selected because they are well-established and appropriate 
across the range of abilities of the participants (young people with 22q11.2DS and control 
siblings). Previous use of these instruments in similar contexts to the study sample is further 
outlined in the supplementary materials (see supplementary Table 2).  
Statistical Analysis 
Statistical analyses were conducted using STATA (version 13.1) (https://www.stata.com/stata-
news/news28-4/stata13.1) and R (version 3.5.0) (R: The R Project for Statistical Computing, 
2018). 
To address aim 1, chi-squared tests and t-tests were used to determine any differences in the 
age and gender between the two groups. Where non-significant, we did not include these two 
variables as covariates in further analyses. Logistic regression analysis was used to establish 
whether group status (child with 22q11.2DS or control sibling) predicted total sleep problem 
score (the sum of positively endorsed sleep items of the CAPA) with age and family 
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relatedness (to indicate that a child with 22q11.2DS and their sibling came from the same 
family) as covariates.  
To address aim 2, we first constructed two-by-two tables for each combination of the 11 sleep 
items in young people with 22q11.2DS, followed by tetrachoric correlation analysis (Pearson, 
1900), which is suitable for dichotomous variables and assumes an underlying normal 
distribution (Ledesma et al. 2011). The 2x2 tables indicated that for several combinations of 
items the cell count for positive endorsement on both items (yes/yes) was zero and that 
therefore a correlation coefficient could not be calculated. This was the case for combinations 
between parasomnia items and several other items: night terrors and hypersomnia, sleep 
walking and hypersomnia; night terrors and tiredness; night terrors and fatigability; nightmares 
and fatigability; and sleep walking and fatigability. Furthermore, some 2x2 tables had very low 
yes/yes cell counts, resulting in low correlations and this involved several combinations with 
the parasomnia item sleep walking, i.e., sleep walking with initial insomnia (r=-0.036); sleep 
walking with early insomnia (r=-0.002); as well as fatigability with middle insomnia (r=-0.01). 
The parasomnia items were furthermore found to not correlate well (sleep walking with 
nightmares (r=0.06, p=0.620); sleep walking with night terrors (r=0.04, p=0.490), except for 
nightmares and night terrors (r=0.400, p<0.001). The parasomnia items also did not differ 
significantly between young people with 22q11.2DS and control siblings (Table 2), indicating 
that they do not represent sleep problems that are specific to young people with the deletion. 
We therefore removed the parasomnia items from the analysis. The items hypersomnia, 
tiredness and fatigability correlated quite strongly (hypersomnia with tiredness r=0.510; 
hypersomnia with fatigability r=0.370; tiredness with fatigability r=.560) and we combined 
these items into a single score capturing tiredness-related sleep problems. Similarly, the items 
early and middle insomnia also correlated quite strongly (r=0.522, p<0.001) and were 
combined (into an item capturing mid/early insomnia). Doing so addressed the almost zero 
correlation between middle insomnia and fatigability. Item combination was as follows: a 
dichotomous variable was created where a positive score on any of the items translated into 
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a positive score on the combined variable. Figure 1 provides a visualisation of the item 
combination procedure followed. This produced a 5-item tetrachoric correlation matrix (see 
supplementary Table 3), which was the basis for exploratory factor analysis (EFA) (Conway 
et al. 2003) to determine the patterns of sleep problems in young people with 22q11.2DS (see 
Table 2).Statistically, combining items that represent a single underlying construct is important 
because it reduces the number of comparisons that would be conducted if each individual item 
was analysed separately and enhances the robustness of the measured concept. Clinically, it 
is important to understand whether sleep problems cluster patterns and have different 
associations with other outcomes such as psychopathology as this can have implications for 
interventions. We decided on the number of factors to be retained from the EFA based on the 
scree plot of eigenvalues (values ≥0.6) (presented in supplementary Figure 2) and 
interpretation of meaningful patterns (Gorsuch, 1983). The factor solution was rotated using 
an oblique solution to maximise interpretation. The rotated factors were not normally 
distributed, determined by looking at the distribution plots and testing using Shapiro-Wilk test 
for normality and assessing Skewness of data. We subsequently calculated the sleep patterns 
by summing the binary sleep problem items that loaded on each factor (“1” = ≥1 positive item; 
“0” = no positive items) for use in further analysis. Spearman correlation analysis was used to 
determine the interrelationship between the resulting patterns of sleep problems. 
For aim 3, hierarchical logistic regression analyses were used to examine the links between 
the patterns of sleep problems (presence or absence of a pattern) in young people with 
22q11.2DS, taking age into account (step 1), with subsequent addition of psychiatric disorder 
symptoms (ADHD, anxiety CD, ODD and ASD), motor coordination problems (DCDQ) and 
cognitive performance (IQ, spatial working memory, sustained and visual attention, spatial 
planning and executive function) each individually (step 2).  
We conducted sensitivity analyses to determine whether relevant factors could explain these 
associations. We examined the links between the sleep patterns (presence or absence) and: 
maternal education level and the children’s melatonin use; epilepsy diagnosis, and physical 
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health problems using logistic regression analyses. For the analyses of the sleep patterns and 
anxiety disorder symptoms, we also removed the sleep-related anxiety symptoms (i.e., ‘unable 
to sleep alone’ and ’separation nightmares’) from the total anxiety symptom score to establish 
if this changed the findings. Other potential confounders (e.g., other medication use) were not 
evaluated because of low prevalence within the sample.  
To correct the analyses for multiple comparisons, we used a Benjamini–Hochberg false 
discovery rate (FDR) rate  of 10% (Benjamini and Hochberg, 1995). The Benjamini-Hochberg 
method ranks the individual p-values from smallest to largest, with the smallest p-value ranking 
as 1. By comparing each individual p-value to the Benjamini-Hochberg critical value 
((rank/total number of tests) * FDR (i.e., 10%)), if the largest p-value in our analyses before 
correction is smaller than its critical value, it is considered significant. Any p-values smaller 
than the largest p-value are also interpreted to be significant. 
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Results 
Sociodemographic information is presented in Table 1. Individuals with 22q11.2DS were 
younger than sibling controls (t=2.09, p=0.040) but there was no difference in gender 
proportions (χ2=0.125, p=0.724) but there were differences in age (t=2.09, p=0.04). 
Prevalence of sleep problems in 22q11.2DS (Aim 1) 
60% of young people with 22q11.2DS had experienced at least one sleep problem 
(22q11.2DS median=1 (range 0-7)) during the past 3 months, compared to 23.1% of sibling 
controls (controls median=0 (range 0-5)) (OR=5.00 p=<0.001) (Table 2). A paired t-test in the 
subsample of children with 22q11.2DS with a participating control sibling (n=63) showed a 
higher report of sleep problems in young people with 22q11.2DS compared to their siblings 
(t=4.56, p<0.001). 
Analysis of the 11 individual CAPA items showed that compared with sibling controls young 
people with 22q11.2DS had higher rates of insomnias, restless and inadequately rested sleep, 
with a borderline trend for tiredness. There were no differences for hypersomnia, fatigability 
and the parasomnia items (nightmares, night terrors and sleepwalking) (Table 2).  
Patterns of sleep problems in 22q11.2DS (Aim 2) 
Exploratory factor analysis indicated that sleep problems in young people with 22q11.2DS 
were captured best by two patterns: restless sleep (see Table 2a) and insomnia (see Table 
2b). The two factors deviated from normality (for restless sleep z=6.39, p<0.001 and p<0.001 
(skewness); for insomnia z=3.53, p=0.0002 and p=0.03 (skewness)) and therefore were 
dichotomised. These patterns correlated (r=0.252, p=0.003), reflecting that children can have 
problems in both domains. 
54.3% (76/140) of young people with 22q11.2DS scored on at least one sleep pattern. Of 
these 76 individuals, 44.7% (34/76) scored positive for the restless sleep pattern only; 21.1% 
(16/76) on the insomnia sleep pattern only and 34.2% (26/76) on both patterns. Neither pattern 
was associated with age (OR=1.01, p=0.912 for restless pattern; OR=0.865, p=0.069 for 
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insomnia pattern), or gender (OR=0.751, p=0.406 for restless pattern; OR=1.12, p=0.767 for 
insomnia pattern). 
Links between sleep patterns and psychiatric symptoms, developmental coordination 
and cognitive function (Aim 3) 
Young people with 22q11.2DS who scored positive for the restless sleep pattern compared to 
those with negative responses had higher rates of any psychiatric disorder, ADHD, anxiety 
disorder and ODD diagnoses (supplementary Table 1; n=0 young people reported CD 
diagnosis). No differences were found in the rates of diagnosis in those who scored positively 
on the insomnia sleep pattern compared to those who did not (supplementary Table 1).  
The restless sleep pattern was associated with increased symptoms of ADHD, anxiety 
disorder, ODD, CD, indicative ASD and indicative DCD, as well as a poorer performance on 
the sustained attention and set shifting ability (perseverative errors on the WCST) tasks (see 
Table 3). following FDR correction (denoted by * in Table 3). 
Post-hoc analysis of ADHD symptoms showed an association with the inattentive (OR=4.95, 
p<0.001), but not the hyperactive (OR=6.81, p=0.104) or combined (OR=1.76, p=0.307) 
subtypes.   
The insomnia sleep pattern showed association with increased symptoms of anxiety disorder, 
CD and indicative DCD as well as impaired performance on the visual attention task (Table 
3). The associations between the restless sleep pattern and sustained attention and the 
insomnia pattern and visual attention disappeared following FDR correction (denoted by * in 
Table 3).  
Comorbid presentation of both sleep patterns with psychiatric symptoms was high (see figures 
1 and 2). Of the 60 young people who scored on the restless sleep pattern, 86.7% (52/60) had 
at least one comorbidity as did 52.4% (22/42) of the young people scoring on the insomnia 
sleep pattern. The most common comorbid presentation for the restless sleep pattern (found 
in 18.6% scoring positive on this pattern) was in combination with symptoms of ADHD, anxiety 
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disorder, CD, ODD and indicative DCD and the most common comorbid presentation for the 
insomnia sleep pattern (35.7%) was in combination with anxiety, CD and DCD.  
Sensitivity analyses 
Neither sleep patterns were associated with family income (OR=0.929, p=0.418 for restless 
pattern; OR=0.925, p=0.432 for insomnia pattern).  
Higher maternal education was associated with reduced risk of a positive score on the restless 
sleep pattern for young people with 22q11.2DS (OR=0.729, p=0.011), but not insomnia pattern 
(OR=0.979, p=0.866). Including maternal education as a covariate in regression analyses, the 
associations between restless sleep and indicative ASD (OR=1.04, p=0.101), conduct 
symptoms (OR=1.30, p=0.139) and oppositional symptoms were lost (OR=1.15, p=0.178) (b 
in Table 3).  
12% (17/140) of young people with 22q11.2DS were using melatonin at the time of 
assessment and 94.1% (16/17) of these reported sleep problems. 68.8% (11/16) scored on 
both patterns; 18.8% (3/16) on the restless sleep pattern and 12.5% (2/16) on the insomnia 
pattern only. Children using melatonin had higher levels of sleep problems (x̅=3.12) compared 
to those not using melatonin (x̅=1.23) with elevated rates of restless sleep (OR=5.26, p=0.006) 
and insomnia (OR=15.8, p<0.001). The young people using melatonin for their sleep problems 
did not appear to have reported fewer sleep problems than young people not taking melatonin. 
Sleep problems were reported despite the melatonin use and furthermore, melatonin use 
appeared to be a proxy for sleep problem severity in our sample (where correcting for it would 
reduce the severity of sleep problems in the sample), we did not include it in our analysis as 
a covariate.  
An epilepsy diagnosis (current or lifetime) was present in 10.7% (15/140) of participants with 
22q11.2DS but was not found to be associated with sleep problems (restless; OR=1.38, 
p=0.457, and insomnia; OR=1.32, p=0.555).  
   
 
16 
 
Physical health problems did not associate with sleep problems: cardiac problems with 
restless sleep (OR=1.82, p=0.094) and insomnia (OR=1.13, p=0.748); respiratory problems 
with restless sleep (OR=1.10, p=0.807 and insomnia OR=0.765, p=0.536) and, skeletal 
problems with restless sleep (OR=1.46, p=0.295) and insomnia (OR=0.899, p=0.786). 
Medication use in the young people with 22q11.2DS included antipsychotic medication 
aripiprazole (n=1) for psychotic experiences; risperidone for mood disorder (n=1); and sodium 
valproate for epilepsy (n=2). None were using ADHD medication. These prevalence’s were 
too low to consider in sensitivity analysis. 
Removal of the sleep-related anxiety symptoms did not change the findings for the links 
between either sleep pattern and anxiety disorder symptoms. 
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Discussion 
This is the first study to systematically investigate the prevalence and nature of sleep problems 
in 22q11.2DS and establishing the links with psychopathology, motor and cognitive function. 
We find high rates of sleep problems affecting around two-thirds of young people with 
22q11.2DS compared to around a quarter of sibling controls. Two patterns of sleep problems 
were found in 22q11.2DS: restless sleep and insomnia, which occurred at rates of 43% and 
30%. Both patterns of sleep problems were associated with elevated symptoms of anxiety 
disorder and indicative DCD. The restless sleep pattern was also associated with increased 
ADHD symptoms and impaired executive function (set shifting ability), and the insomnia sleep 
pattern with conduct disorder symptoms.  
Prevalence of sleep problems in 22q11.2DS  
Young people with 22q11.2DS showed a higher prevalence of sleep problems at 60% than 
reported for young people in the general population (Owens and Mindell, 2011). Our findings 
add to a scarce literature of sleep problems in young people with genetic syndromes (De 
Leersnyder et al., 2001; Williams et al., 2006; Trickett et al., 2018). 23% of sibling controls 
reported sleep problems which is comparable to rates in neurotypical childhood of 25-50% 
(Owens and Mindell, 2011). Paired analysis in a subsample the of young people with 
22q11.2DS with a participating sibling showed no association between their sleep problems. 
This is consistent with sleep problems in 22q11.2DS being specific to the syndrome and may 
suggest that environmental factors contributing to risk of sleep problems could specifically 
affect young people with 22q11.2DS with the same effect not shared by siblings. However, 
these hypotheses need to be evaluated in more detail. 
Patterns of sleep problems in 22q11.2DS  
Restless sleep and insomnia were identified as the two patterns of sleep problems in 
22q11.2DS, with a subset of individuals scoring on both patterns. It is important to understand 
the particular sleep problems an individual is affected by for effective treatment. Young people 
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whose sleep problems manifest around tiredness could be treated differently to those 
experiencing delays in sleep onset (Kotagal and Pianosi, 2006; Malow et al., 2016).   
Links between sleep patterns and psychiatric symptoms, developmental coordination 
problems and cognitive performance 
ADHD symptoms were linked to increased likelihood of scoring on the restless sleep pattern. 
This results is in line with previous studies of idiopathic (Lycett et al., 2015) young people with 
ADHD showing that sleep problems including sleep-related breathing disorders (Chervin et al. 
1997; Gozal et al. 2011) and restless legs syndrome (Chervin et al. 2002) are common in this 
population. We have previously reported a higher incidence of the inattentive ADHD subtype 
in 22q11.2DS compared to young people with idiopathic ADHD (Niarchou et al., 2018) and 
are now finding that the link between ADHD symptoms and restless sleep is driven by 
inattentive ADHD. These results should be interpreted with caution as only three individuals 
in our 22q11.2DS sample had the hyperactive ADHD subtype. 
Anxiety symptoms were associated with both the restless and insomnia sleep patterns and 
these links remained in sensitivity analysis removing sleep-related anxiety symptoms from the 
total symptom score. There are reports of links between sleep problems and anxiety 
symptoms in young people with other genetic syndromes (Bassell et al., 2015) as well as in 
idiopathic samples. Insomnia is a common complaint in anxiety disorders (Vriend and Corkum, 
2011) as is fatigue (Chorney et al., 2007) and prior studies have identified links between limb 
movements during sleep and generalised anxiety (Saletu et al. 2002; Staner 2003). Our 
findings are cross-sectional and cannot resolve whether anxiety symptoms preceded sleep 
problems, however they do highlight the need for increased awareness of sleep problems in 
this population and may be coupled with findings that early interventions may prevent sleep 
problems from continuing into later life (Benca et al. 1997; Staner 2003; Turnbull et al. 2013).  
CD and ODD symptoms were associated with the restless sleep pattern (Eastabrook et al., 
2003) and CD symptoms also with the insomnia pattern. Children with CD and ODD are 
reported to have more sleep problems than typically developing children including increased 
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nocturnal awakenings and delayed sleep onset, and conduct problems have also been 
reported to show particular links with sleep-related breathing disorders and periodic limb 
movements (Eastabrook et al., 2003). The associations between restless sleep pattern and 
symptoms of CD and ODD was lost considering the effects of maternal education. 
22q11.2DS represents one of the strongest risk factors for the development of psychotic 
disorder and schizophrenia (Monks et al., 2014; Schneider et al., 2014). The current sample 
is too young to study how sleep problems relate to risk of psychosis and schizophrenia, 
however, this is an important topic for future research, including longitudinal studies (Ferrarelli 
et al. 2007; Pritchett et al. 2012; Wulff et al. 2012).  
Elevated indicative ASD symptoms were associated with the restless sleep pattern. This is in 
line with previous reports of sleep problems being common in idiopathic samples of children 
with ASD (Reynolds and Malow 2011; Cohen et al. 2014; Robinson-Shelton and Malow 2016), 
including parasomnias, bedtime resistance, insomnia and daytime sleepiness (Johnson and 
Malow 2008; Souders et al. 2009).  The association we found was lost in sensitivity analyses 
considering the effects of maternal education. 
As we have previously reported, the rate of motor coordination problems in 22q11.2DS is very 
high (80%) (Cunningham et al., 2017). We now find that indicative DCD is associated with 
both restless and insomnia sleep patterns. There are few studies reporting sleep problems in 
DCD in general, with the exception of a few reports in children of disturbed sleep patterns 
(Wiggs et al. 2016) including bedtime resistance and daytime sleepiness (Barnett and Wiggs, 
2012) and impaired sleep quality (Wiggs et al. 2005). Distinguishing these associations is 
important for improved understanding of the mechanisms that could link motor coordination 
with sleep. 
The restless sleep pattern was associated with impairments in executive function and 
sustained attention and the insomnia pattern with impairment in visual attention. Only the link 
between the restless pattern and poor executive function remained after correction for multiple 
   
 
20 
 
testing. Cognitive flexibility and engagement of the frontal cortex is necessary for efficient 
executive function with studies observing a detrimental impact of sleep deprivation on set-
shifting ability using the same test we used (WCST) in idiopathic samples (Maddox et al., 
2009). Anatomical brain changes in 22q11.2DS (Sun et al., 2018) could affect normative 
frontal cortical engagement and potentially contribute to atypical sleep neurophysiology 
(Muzur et al. 2002).  
Sensitivity analyses 
Highest maternal education associated with reduced risk for restless sleep pattern 
Higher maternal education level was associated with reduced risk of scoring on the restless 
sleep pattern. There is some evidence that parents with higher education attainment may be 
better informed on practices that can improve the quality of a child’s sleep, with specific 
evidence of long-lasting effects in children with NDDs (Hiscock et al., 2015; Papadopoulos et 
al., 2015) including ASD (Trickett et al. 2017). There is clear evidence for higher maternal 
education to be linked to fewer childhood ODD (Rydell, 2010) and CD symptoms (Etherington 
et al., 2016). Capitalising on improving parental sleep education and family involvement to 
improve behaviour more generally but particularly sleep behaviours and hygiene in children 
with 22q11.2DS could help lessen sleep problems.  
Melatonin use in 22q11.2DS  
Melatonin is commonly prescribed in young people with insomnia-related problems as it 
mimics endogenous melatonin release, thought to positively influence sleep onset (Ivanenko 
et al., 2003). Of the individuals in our cohort on melatonin, all but one reported sleep problems.  
Sleep problems were higher in those on melatonin compared to those who were not, 
suggesting that melatonin was used by individuals with more severe problems and where 
sleep problems persist.  
Sleep-related anxiety symptoms  
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Although a link between sleep problems and anxiety has been reported in genetic syndromes 
(Bassell et al., 2015) as well as idiopathic populations (Bélanger et al., 2004), but it was 
unclear to what extent the association is driven by sleep-related anxieties. We found the 
association between the restless pattern of sleep problems and symptoms of anxiety remained 
after excluding the anxiety-related sleep problem items, suggesting that sleep problems may 
not be driven by anxieties relating specifically to sleep such as co-sleeping and bedtime 
resistance.  
Epilepsy diagnosis did not explain associations with patterns of sleep problems  
An association between the patterns of sleep problems and an epilepsy diagnosis was not 
evident, suggesting that the sleep problems reported in this study population might not 
manifest directly from neurological problems attributable to epilepsy. However, the association 
between epilepsy and sleep problems is reported in some studies of neurodevelopmental 
disorders, suggesting that a high prevalence of sleep problems can associate with seizure-
related activity especially during sleep onset and waking (Accardo and Malow, 2014).  
Strengths and Limitations 
To our knowledge, this is the first study to systematically investigate sleep problems in 
22q11.2DS. Our sample is large, including a valuable sibling control group, which allowed us 
to quantify the extent to which sleep problems are increased in 22q11.2DS and to conduct 
pairwise comparisons between sleep problems in young people with the deletion and their 
siblings, considering background genetic and environmental factors shared by family 
members. Available demographic and medication data allowed us to conduct sensitivity 
analyses to gain further insights into the nature of the relationships.  
The measures we used, despite being gold-standard research diagnostic psychiatric tools, did 
not include objective monitoring of sleep problems or the young persons’ own accounts of 
sleep problems. Parents might not be able to accurately report on all night-time activities and 
behaviours, particularly in older children, so using objective measures such as sleep 
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electroencephalography (EEG) and cardio-respiratory polygraphy would help to further 
explore sleep problems in 22q11.2DS. We did not include assessments of craniofacial 
abnormalities or sleep apnoea in this study and can therefore not account for the effect of 
these variables on our findings.  
The current study established the rates of sleep problems in 22q11.2DS and the links with 
other problems these young people frequently face, but further research is now needed to 
elucidate the underlying causes. One or more of the genes within the deleted region may 
increase risk. It is also possible that structural brain abnormalities and atypical brain 
physiology (Flahault et al. 2012; Andrade et al. 2013; Scott et al. 2016; Sun et al. 2018) 
contribute to risk of sleep problems either directly, or indirectly through the consequences of 
psychiatric and cognitive deficits. Future genetic, longitudinal and brain studies (imaging, 
EEG) may shed light on these questions.  
Clinical implications and Future Research Directions 
Clinicians should be aware of the high rates of sleep problems in young people with 
22q11.2DS and that these index several psychiatric, motor and cognitive problems. A sleep 
history could make it clearer which sleep problem a child has and could provide insights into 
the other problems they may experience. The restless sleep pattern may also explain to a 
degree the high rates of fatigue reported by other researchers in 22q11.2DS (Vergaelen et al., 
2017).  
Our findings have implications for better understanding sleep problems and the relationship 
with psychopathology in young people in non-high-risk samples. A dedicated sleep study 
examining 22q11.2DS neurophysiology during sleep would help contribute to understanding 
the origin of sleep problems and could inform better sleep interventions in this cohort.  
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Figure 1 The UpSetR diagram based on the combined presentation of symptoms across the restless sleep pattern (restless sleep) and attention-deficit hyperactivity disorder (ADHD); indicative autism 
spectrum disorder (ASD); conduct disorder (CD); anxiety disorder (anxiety); oppositional defiant disorder (ODD); and indicative developmental coordination disorder (DCD). The filled black circles
represent the presence of symptoms for each domain and empty circles show the absence of symptomology. This diagram includes n=88 young people with 22q11.2DS because of missingness in
the SCQ (n=12) and DCDQ (which was introduced later on in our study; n=43). 
  
Figure 2 The UpSetR based on the combined presentation of symptoms across the insomnia sleep pattern and conduct disorder (CD); anxiety disorder and indicative developmental coordination
disorder (DCD). The filled black circles represent the presence of symptoms for each domain and empty circles show the absence of symptomology. This diagram includes n=97 young people with
22q11.2DS because of missingness in the DCDQ (which was introduced later on in our study). 
Table 1 Demographic information on participating families 
 
 
 
 
 
 
 % 
Family ethnic background 
 European 85.9 
 Mixed 4.23 
 Non-European 2.11 
 Unknown  10.6 
Highest maternal education qualification 
 No qualifications  8.57 
 Low: O-levels or GCSEs 22.9 
 Middle: A-levels/Highers or vocational training 23.6 
 High: University degree and/or other higher postgraduate qualification 36.4 
 Other 3.52 
 Unknown  3.57 
Family income 
 ≤19,999 20.4 
 20,000-39,000 23.9 
 40,000-59,000 18.3 
 ≥60,000 23.9 
 Unknown 13.4 
Age, years: mean (s.d.) range p 
 Probands 10.1 (2.46) 6.02-17.1 Siblings 10.8 (2.26) 6.29-16.6 0.04 
Gender, n (%)  
 Probands 63/140 F (45%) Siblings 28/65 F (43.1%) 0.796 
Table 2 Prevalence of sleep problems items in young people with 22q11.2DS and sibling controls 
  Sleep items, n (%)  22q11.2DS Sibling controls OR 
95% Cl for means/medians 
differences p 
At least one sleep problem  60% (84/140) 23.1% (15/65) 5.00 2.56-9.76 <0.001 
Total number of sleep 
problems 
 Median score (s.d., range) 
Median score 
(s.d., range)    
 1 (1.76, 0-7) 0 (1.05, 0-5) 1.86 1.34-2.57 <0.001 
  Total, n (%)   
Hypersomniaa  8 (5.71) 1 (1.54) 3.88 0.475-31.7 0.206 
Restless sleepa  45 (32.1) 4 (6.15) 7.22 2.47-21.1 <0.001 
Inadequately resteda  27 (19.3) 1 (1.54) 15.3 2.03-115 0.008 
Tirednessa  15 (10.7) 1 (1.54) 7.68 0.992-59.4 0.051 
Fatigabilitya  7 (5.00) 1 (1.54) 3.37 0.406-28.0 0.261 
Insomnias       
 Initialb 32 (22.9) 7 (10.8) 2.46 1.02-5.91 0.045 
 Middleb 23 (16.4) 1 (1.54) 12.6 1.66-95.3 0.014 
 Earlyb 13 (9.29) 0 (0.00) -  - 
Parasomnias   
 Nightmares 16 (11.4) 6 (9.23) 1.27 0.472-3.41 0.637 
 Night terrors 8 (5.71) 2 (3.08) 1.91 0.384-9.25 0.422 
 Sleepwalking 11 (7.86) 4 (6.15) 1.30 0.398-4.25 0.664 
Age was included as a covariate in the regression analyses. aSleep problems indexing restless sleep/tiredness sleep pattern; bSleep problems 
indexing insomnia pattern (see aim 2).  
 
 
Table 3 Associations between patterns of sleep problems, symptom counts of psychopathology, IQ and cognitive performance 
in young people with 22q11.2DS 
Measure  Restless sleep pattern 
Psychopathology (symptoms counts) 
  OR S.E. 95% Cl p 
Attention–deficit hyperactivity disorder 1.16 0.047 1.07-1.25 <0.001 
Anxiety disorder 1.10 0.039 1.03-1.19 0.006 
Conduct disorder  1.41 0.237 1.02-1.96 0.038a 
Oppositional defiant disorder  1.29 0.137 1.05-1.59 0.015a 
Indicative autism-spectrum disorder 1.05 0.027 1.00-1.10 0.048a 
Indicative developmental coordination disorderb 0.968 0.014 0.940-0.996 0.023 
IQ     
Full-scale IQ  0.980 0.0151 0.951-1.01 0.194 
Performance IQ  0.984 0.0156 0.953-1.01 0.296 
Verbal IQ  0.981 0.0137 0.955-1.01 0.175 
Cognitive processing     
Processing speed (five-choice reaction time) 0.938 0.096 0.769-13.14 0.525 
Sustained attention (rapid visual processing) 0.832 0.076 0.696-0.995 0.044*
Visual attention (match to sample) 0.997 0.026 0.948-1.05 0.900 
Spatial planning 0.950 0.192 0.640-1.41 0.800 
Spatial working memory 0.909 0.174 0.625-1.32 0.616 
Set shifting ability 0.973 0.001 0.954-0.993 0.008 
Errors on the Wisconsin Card Sorting Task 1.02 0.010 0.998-1.04 0.074 
Measure Insomnia pattern 
Psychopathology (symptoms counts)     
  OR S.E. 95% Cl p 
Attention–deficit hyperactivity disorder 1.04 0.042 0.961-1.12 0.338 
Anxiety disorder 1.07 0.036 1.00-1.14 0.045 
Conduct disorder 1.53 0.278 1.07-2.18 0.020 
Oppositional defiant disorder  1.22 0.133 0.980-1.51 0.075 
Indicative autism-spectrum disorder  1.04 0.027 0.992-1.10 0.095 
Indicative developmental coordination disordera 0.955 0.017 0.922-0.989 0.009 
IQ     
Full-scale IQ  0.988 0.017 0.956-1.02 0.467 
Performance IQ  0.982 0.018 0.949-1.02 0.315 
Verbal IQ  0.992 0.015 0.963-1.02 0.595 
Cognitive processing     
Processing speed (five-choice reaction time) 1.15 0.157 0.881-1.50 0.303 
Sustained attention (rapid visual processing) 0.995 0.061 0.882-1.12 0.941 
Visual attention (match to sample) 0.945 0.026 0.895-0.998 0.042*
Spatial planning 1.21 0.277 0.771-1.89 0.410 
Spatial working memory 1.09 0.227 0.729-1.64 0.663 
Set shifting ability 0.989 0.010 0.970-1.01 0.301 
Errors on the Wisconsin Card Sorting Task 1.01 0.010 0.989-1.03 0.381 
aAssociations were lost following sensitivity analyses; bDevelopmental coordination disorder is reversed scored; *Associations were 
lost following correcting FDR correction for multiple testing 
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Table 1 Associations between the restless and insomnia sleep patterns and psychiatric disorder diagnoses in young people with 22q11.2DS  
 Restless sleep  Insomnia  Both patterns vs. No pattern 
Psychiatric Disorder (research diagnosis) Scored, n (%) No score, n (%) p Scored, n (%) No score, n (%) p Scored, n (%) No score, n (%) p 
 
Any Psychiatric Disorder 48 (80.0) 38 (52.8) 0.001 29 (74.4) 57 (61.3) 0.151 
 
20 (76.9) 
 
29 (49.2) 
 
0.017 
ADHD diagnosis 33 (55.0) 21 (26.3) 0.001 18 (42.9) 36 (36.7) 0.495 13 (50) 16 (25) 0.021 
Any anxiety diagnosis 20 (33.3) 15 (18.8) 0.049 12 (28.6) 23 (23.5) 0.523 8 (30.8) 11 (17.2) 0.152 
CD diagnosis  0 (0) 0 (0) - 0 (0) 0 (0) - 0 (0) 0 (0) - 
ODD diagnosis 17 (28.8) 8 (10.5) 0.007 11 (28.2) 14 (14.6) 0.065 9 (34.6) 7 (11.5) 0.011 
Indicative ASD* 25 (43.9) 20 (29.4) 0.094 18 (47.4) 27 (31.0) 0.080 10 (41.7) 12 (22.2) 0.078 
Indicative DCD* 38 (88.4) 41 (76) 0.117 24 (88.9) 55 (78.6) 0.241 16 (88.9) 33 (73.3) 0.180 
IQ Mean score (s.d) 
Mean score 
(s.d) p 
Mean score 
(s.d) 
Mean score 
(s.d) p 
Mean score 
(s.d) 
Mean score 
(s.d) p 
 
Full-scale IQ  
 
74.9 (12.1) 
 
77.9 (12.3) 
 
0.194 
 
75.3 (10.6) 
 
77.1 (12.8) 
 
0.471 
 
75.3 (11.2) 
 
78.4 (12.8) 
 
0.313 
Performance IQ  77.1 (11.4) 79.3 (12.0) 0.298 76.6 (9.85) 79.0 (12.4) 0.317 77.9 (10.6) 80.5 (12.5) 0.403 
Verbal IQ  76.5 (13.4) 79.9 (13.5) 0.176 77.4 (12.3) 78.8 (14.0) 0.598 76.6 (12.0) 80.2 (13.6) 0.287 
Cognitive processing Median score (s.d) 
Median score 
(s.d) p 
Median score 
(s.d) 
Median score 
(s.d) p 
Median score 
(s.d) 
Median score 
(s.d) p 
 
Processing speed (five-choice reaction time) 0.290 (2.31) 0.380 (1.59) 0.995 0.090 (1.21) 0.380 (2.15) 0.825 
 
0.090 (1.12) 0.040 (1.64) 0.717 
Sustained attention (rapid visual 
processing) -2.18 (4.82) -1.31 (2.01) 0.03 -2.22 (2.42) -1.71 (3.95) 0.823 -2.26 (2.53) -1.26 (1.95) 0.116 
Visual attention (match to sample) 42 (7.58) 42 (39.7) 0.780 41 (8.67) 42 (6.88) 0.043 41 (7.90) 42 (6.63) 0.179 
Spatial planning -1.05 (0.963) -1.05 (1.06) 0.847 -1.05 (0.994) -1.05 (1.03) 0.578 -0.816 (0.915) -0.910 (1.05) 0.528 
Spatial working memory -1.18 (0.948) -1.04 (0.922) 0.989 -1.37 (0.919) -1.04 (0.936) 0.390 -1.07 (0.906) -0.990 (0.913) 0.675 
Set shifting ability 82.0 (19.4) 90.5 (22.0) 0.011 84 (22.1) 88 (21.3) 0.430 84.5 (19.0) 92 (20.9) 0.088 
Errors on WCST 101 (21.6) 93.5 (20.1) 0.096 98 (19.3) 97.5 (21.7) 0.496 101 (18.0) 94 (20.1) 0.128 
 
 
 
 
 
 
Table 2 The assessments conducted in the study and reliability measures/articles in similar populations  
Assessment Reliability measures  
Child and Adolescent Psychiatric Assessment (CAPA) 
The Child and Adolescent Psychiatric Assessment (CAPA), Angold, Adrian et al. Journal of the American 
Academy of Child & Adolescent Psychiatry, Volume 39, Issue 1, 39 – 48; Wamboldt MZ, Wasmboldt FS, 
Gavin L & McTaggart S (2001) A parent-child relationship scale derived from the Child and Adolescent 
Psychiatric Assessment (CAPA). Journal of the American Academy of Child and Adolescent Psychiatry, 
40:945-953. 
Social Communication Questionnaire (SCQ) Berument, S.K., M. Rutter, C. Lord, A. Pickles & A. Bailey. 1999. Autism screening questionnaire: diagnostic validity BrJ psychiatry 175: 444-51. 
Developmental Coordination Disorder Questionnaire (DCDQ) 
Einfeld, S.L. & B.T. Tonge. Manual for the Developmental Behaviour Checklist (Second Edition) - Primary 
Carer Version (DBC-P) and Teacher Version (DBC-T).   2002. Melbourne and Sydney, Monash University 
Centre for Developmental Psychiatry and Psychology and School of Psychiatry, University of New South 
Wales. 
The Cambridge Neuropsychological Test Automated Battery (CANTAB) 
http://www.cantab.com. Accessed 26/03/2008; Matsuura N, Ishitobi M, Arai S, Kawamura K, Asano M, 
Inohara K, Narimoto T, Wada Y, Hiratani M, Kosaka H. Distinguishing between autism spectrum disorder 
and attention deficit hyperactivity disorder by using behavioral checklists, cognitive assessments, and 
neuropsychological test battery. Asian J Psychiatr. 2014 Dec; 12:50-7. 
The Weschler Abbreviated Scale of Intelligence (WASI) Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: Psychcorp; 1999; Bishop SL, Farmer C, Thurm A. Measurement of nonverbal IQ in autism spectrum disorder: scores in young 
adulthood compared to early childhood. J Autism Dev Disord. 2015;45(4):966-74.
The Wisconsin Card Sorting Task (WCST) 
Ozonoff, S. (1995). Reliability and validity of the Wisconsin Card Sorting Test in studies of 
autism. Neuropsychology, 9(4), 491-500; Stephen C. Bowden, Kylie S. Fowler, Richard C. Bell, Gregory 
Whelan, Christine C. Clifford, Alison J. Ritter & Caroline M. Long (1998) The Reliability and Internal 
Validity of the Wisconsin Card Sorting Test, Neuropsychological Rehabilitation, 8:3, 243-
254, DOI: 10.1080/713755573 
 
 
  
 
 
 
Table 3 Factor loadings and variance for the exploratory factor analysis (EFA) after rotation of the matrix 
Variables  Restless (factor 1) Insomnia (factor 2) 
Initial insomnia -0.0157 0.8027 
Middle and Early insomnia 0.0492 0.8261 
Tiredness, Fatigue and Hypersomnia 0.7860 -0.0569 
Restless sleep 0.7578 0.0.342 
Inadequately rested  0.6406 0.1549 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Visualisation of the two-factor outcome from the exploratory factor analysis (EFA). After exclusion of the parasomnia items (nightmares, night terrors and sleep walking), the hypersomnia, 
tiredness and fatigability were combined into one item ‘tiredness-related’ because they correlated strongly. Similarly, early and middle insomnia were combined. EFA indicated that a structure of two 
patterns ‘restless sleep’ and ‘insomnia’ best described the sleep problems of children with 22q11.2DS. 
 
 
0
.
5
1
1
.
5
2
2
.
5
E
i
g
e
n
v
a
l
u
e
s
1 2 3 4 5Number
Scree plot of eigenvalues after factor
Figure 2 Scree plot showing evidence to support the decision to use two factors in the exploratory factor analysis 
